IP Library Granted Patent US 8,106,155
Granted Patent B2
US 8,106,155 · App. 10/170,343 · Granted Jan 31, 2012

Test kit for determining process for determining antibiotics containing a beta-lactam ring in a biological fluid

Assignee: Neogen Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,106,155
App. No.
10/170,343
Granted
Jan 31, 2012
Kind
B2
Abstract

A test kit for detecting an antibiotic or antibiotics containing a β-lactam ring in a biological fluid is provided. The test kit includes at least one recognition agent, which is a receptor which specifically binds to antibiotics containing a β-lactam ring and is obtained from Bacillus licheniformis . The test kit further contains at least one reference antibiotic immobilized on a solid support.

Claims (39)

1. A test kit for detecting an antibiotic or antibiotics containing a β-lactam ring in a biological fluid, the test kit comprising:

at least one recognition agent, which is a receptor which specifically binds to antibiotics containing a β-lactam ring, and is obtained from Bacillus licheniformis , and is a BlaR receptor or a BlaR-CTD receptor; and

at least one reference antibiotic immobilized on a solid support;

wherein the antibiotic or antibiotics are detected by the test kit in five (5) minutes or less.

2. The test kit according to claim 1 , wherein the receptor which specifically binds to antibiotics containing a β-lactam ring is the BlaR-CTD receptor.

3. The test kit according to claim 1 , wherein the receptor which specifically binds to antibiotics containing a β-lactam ring is coupled to a labelling agent selected from the group consisting of metallic colloidal particles, colloidal particles of selenium, colloidal particles of carbon, colloidal particles of sulphur, colloidal particles of tellurium, and colloidal particles of colored synthetic latices.

4. The test kit according to claim 1 , wherein the receptor which specifically binds to antibiotics containing a β-lactam ring is coupled to a labelling agent which is a fluorescent substance.

5. The test kit according to claim 1 , wherein the receptor which specifically binds to antibiotics containing a β-lactam ring is coupled to a labelling agent which is an enzyme.

6. The test kit according to claim 5 , wherein the receptor which specifically binds to antibiotics is chemically or genetically coupled to the enzyme.

7. The test kit according to claim 1 , wherein the solid support is selected from tubes, plates or rods coated with the reference antibiotic.

8. The test kit according to claim 1 , wherein the solid support is a test device comprising:

a solid support which has a first and second end, to which are attached, successively, starting from the first end,

a membrane for purifying the biological fluid,

a membrane on which at least one reference antibiotic is immobilized, and

an absorbent membrane.

9. The test kit according to claim 1 , wherein the solid support consists of a set of magnetic or non-magnetic beads.

10. The test kit according to claim 1 , wherein the antibiotic or antibiotics are detected in less than five (5) minutes.

11. The test kit according to claim 1 , wherein the antibiotic or antibiotics are detected in three (3) minutes.

12. The test kit according to claim 1 , wherein the antibiotic or antibiotics is at least one of penicillin G, ampicillin, amoxycillin or cloxacillin.

13. The test kit according to claim 1 , which is capable of detecting penicillin G at a concentration of 3 ppb.

14. The test kit according to claim 1 , which is capable of detecting ampicillin at a concentration of 4 ppb.

15. The test kit according to claim 1 , which is capable of detecting amoxycillin at a concentration of 4 ppb.

16. The test kit according to claim 1 , which is capable of detecting cloxacillin at a concentration of 4 ppb.

17. The test kit according to claim 1 , wherein:

the test kit is capable of detecting penicillin G at a concentration of 3 ppb;

the test kit is capable of detecting ampicillin at a concentration of 4 ppb;

the test kit is capable of detecting amoxycillin at a concentration of 4 ppb; and

the test kit is capable of detecting cloxacillin at a concentration of 4 ppb.

18. The test kit according to claim 2 , wherein:

the test kit is capable of detecting penicillin G at a concentration of 3 ppb;

the test kit is capable of detecting ampicillin at a concentration of 4 ppb;

the test kit is capable of detecting amoxycillin at a concentration of 4 ppb; and

the test kit is capable of detecting cloxacillin at a concentration of 4 ppb.

19. The test kit according to claim 2 , wherein the receptor which specifically binds to antibiotics containing a β-lactam ring is coupled to a labeling agent selected from the group consisting of metallic colloidal particles, colloidal particles of selenium, colloidal particles of carbon, colloidal particles of sulphur, colloidal particles of tellurium, and colloidal particles of colored synthetic latices.

20. The test kit according to claim 2 , wherein the solid support is a test device comprising:

a solid support which has a first and second end, to which are attached, successively, starting from the first end,

a membrane for purifying the biological fluid,

a membrane on which at least one reference antibiotic is immobilized, and

an absorbent membrane.

Assignments (2)
SECURITY INTEREST Recorded Sep 2, 2022
From: NEOGEN CORPORATION; NEOGEN FOOD SAFETY US HOLDCO CORPORATION
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 061372/0264 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2006
From: UCB, S.A.
To: NEOGEN CORPORATION
Reel/Frame 017982/0180 →
Priority Claims (1)
BE 9800485 · Jun 25, 1998 · national
Continuity (2)
Division 09276923 · Mar 26, 1999
Related Publication 20020192715A1 · Dec 19, 2002